Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Look Who's Talking… About Liquid Biopsy Technology

I've told this story before, but it bears repeating here...

Back in April 2015, about a month after I originally recommended "Liquid Biopsy" stock TrovaGene Inc. (Nasdaq: TROV), biotech-sector executive Tina Nova wrote in a Wired magazine essay that the still-in-development cancer-screening technology is "the most exciting thing I've seen since I started my career."

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK